TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$1.87+0.05 (+2.75%)
Close on Nov 13, 2026Market cap $21.64MP/E 187.0Yield –
TherapeuticsMD price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
TherapeuticsMD's price to book ratio was 0.8× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.4× to 108.2×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | +0.1 |
| 2025 | Dec 31, 2025 | 0.7× | +0.3 |
| 2024 | Dec 31, 2024 | 0.4× | −0.5 |
| 2023 | Dec 29, 2023 | 0.8× | −45.7 |
| 2020 | Apr 30, 2020 | 46.6× | −32.7 |
| 2019 | Oct 31, 2019 | 79.3× | +72.6 |
| 2018 | Dec 31, 2018 | 6.7× | −2.0 |
| 2017 | Dec 29, 2017 | 8.7× | +1.0 |
| 2016 | Dec 30, 2016 | 7.8× | −16.0 |
| 2015 | Dec 31, 2015 | 23.8× | +12.9 |
| 2014 | Dec 31, 2014 | 10.9× | −1.2 |
| 2013 | Dec 31, 2013 | 12.2× | – |
See a number that looks wrong?